Search

everythinglearnresearchcommunity

for

Search:↓

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

COVID-19 can cause different skin issues, including rashes and hair loss.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Many research paper titles in dermatology journals lack scientific precision.

Thyroid function may influence hair loss after COVID-19.

Patients with chronic skin disorders often experience depression, anxiety, and reduced quality of life and may benefit from psychiatric help.

Certain gene variations and different levels of BDNF and CRH hormones are linked to vitiligo.

COVID-19 patients with skin signs often stayed in the hospital for less time than those without skin signs.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

The Megsin-Cre transgene is a new tool for genetic manipulation in the skin and upper digestive tract.

People with Alopecia Areata are more likely to have prediabetes and obesity.

Imbalance in scalp bacteria can affect hair and scalp health, potentially leading to conditions like hair loss, psoriasis, and dandruff.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Covers common skin issues in kids, their diagnosis, treatment, and need for specialist care.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Latanoprostene bunod effectively lowers eye pressure and is better tolerated than other glaucoma medications.

Combining PRP with minoxidil and finasteride is the most effective treatment for male hair loss.

Stem cell treatments show promise for hair loss but need more research.

Microneedling with betamethasone led to almost complete hair regrowth in severe alopecia areata.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.